Literature DB >> 25482317

PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease.

Giovanni Musso1, Maurizio Cassader2, Roberto Gambino2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25482317     DOI： 10.1002/hep.27643

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  13 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 2.  Association of metabolic dysfunction-associated fatty liver disease with kidney disease.

Authors:  Ting-Yao Wang; Rui-Fang Wang; Zhi-Ying Bu; Giovanni Targher; Christopher D Byrne; Dan-Qin Sun; Ming-Hua Zheng
Journal:  Nat Rev Nephrol       Date:  2022-01-10       Impact factor: 28.314

Review 3.  Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect.

Authors:  Rajiv Heda; Masahiko Yazawa; Michelle Shi; Madhu Bhaskaran; Fuad Zain Aloor; Paul J Thuluvath; Sanjaya K Satapathy
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

4.  Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.

Authors:  Kentaro Oniki; Junji Saruwatari; Tomoko Izuka; Ayami Kajiwara; Kazunori Morita; Misaki Sakata; Koji Otake; Yasuhiro Ogata; Kazuko Nakagawa
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

Review 5.  Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review.

Authors:  Elina M Petäjä; Hannele Yki-Järvinen
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

Review 6.  Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD.

Authors:  Viera Kupčová; Michaela Fedelešová; Jozef Bulas; Petra Kozmonová; Ladislav Turecký
Journal:  Int J Environ Res Public Health       Date:  2019-09-24       Impact factor: 3.390

Review 7.  Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives.

Authors:  Marcello Dallio; Mario Romeo; Antonietta Gerarda Gravina; Mario Masarone; Tiziana Larussa; Ludovico Abenavoli; Marcello Persico; Carmelina Loguercio; Alessandro Federico
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

8.  Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children.

Authors:  Alessia Di Costanzo; Lucia Pacifico; Laura D'Erasmo; Luca Polito; Michele Di Martino; Francesco Massimo Perla; Ludovica Iezzi; Claudio Chiesa; Marcello Arca
Journal:  Int J Mol Sci       Date:  2019-09-09       Impact factor: 5.923

9.  Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease.

Authors:  Jian-Ting Wu; Shou-Sheng Liu; Xiang-Jun Xie; Qun Liu; Yong-Ning Xin; Shi-Ying Xuan
Journal:  Lipids Health Dis       Date:  2020-02-24       Impact factor: 3.876

10.  Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant.

Authors:  Anna Di Sessa; Giuseppina Rosaria Umano; Grazia Cirillo; Antonio Paride Passaro; Valentina Verde; Domenico Cozzolino; Stefano Guarino; Pierluigi Marzuillo; Emanuele Miraglia Del Giudice
Journal:  World J Gastroenterol       Date:  2020-09-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.